Diadexus (DDXS) Stock Price, News & Analysis

Company Overview

Diadexus, Inc. was a biotechnology and medical diagnostics company focused on developing and commercializing blood tests for cardiovascular disease risk assessment. Its principal product was the PLAC Test, which measured lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme associated with vascular inflammation and atherosclerosis.

The PLAC Test was designed to help healthcare professionals evaluate a patient’s risk of coronary heart disease and ischemic stroke when used alongside other clinical information. The company’s activities centered on cardiovascular biomarker research, laboratory diagnostics, and the commercialization of testing products for use by physicians and clinical laboratories.

Diadexus was based in the United States and primarily served the U.S. medical and laboratory testing markets. Publicly available information about its later operations, current leadership, and ongoing business activities is limited, and the company is generally associated with its historical cardiovascular diagnostics business.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 30 shs
• Average Volume: 15,481 shs
• Market Capitalization: $53 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 10/26/2015
• Today: 9/25/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:DDXS
• CIK: 1036968
• Web: www.diadexus.com
• Phone: (650) 246-6400
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 4,100,000
• Free Float: N/A
• Market Cap: $53 thousand
• Optionable: Not Optionable
• Beta: N/A